Replicel just tweeted they're bringing their injector to the market in 12 months.
Get the injector but no RCH-01 to inject.
Shame.
The injector on the way to the market, means that phase II can start in EU, since they didn't want to start before the CE approval of the injector in the european market.
So its actually positive
-edit-
RepliCel CEO Provides 2019 Shareholder Update
march 5th 2019
RCH-01 – RepliCel’s cell therapy for the treatment of Androgenic Alopecia has been the subject of a successful phase 1 trial in Europe and a clinical study now complete in Japan. Shiseido is expected to announce soon whether it will commercially launch the product in Japan or conduct further development and clinical testing. RepliCel will not plan for a phase 2 clinical trial of this product until it has the RCI-02 injector commercially available to use in such a trial and it has clarity from Shiseido regarding its plans for the product in Japan.
Last edited:
